ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
3-Benzofuranone Based Asymmetric Guest Nonfullerene Acceptors for Reduced Voltage Loss.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Finding solutions that enable improvements in efficiency while enhancing stability remains a major challenge in the field of organic solar cells. In this paper, we select 3-benzofuranone and its monofluorinated derivatives, namely 5-fluoro-3-benzofuranone and 6-fluorobenzofurane-3(2H)-one, as luminescent end groups and synthesize three asymmetric nonfullerene acceptors, denoted as ZHY1, ZHY2, and ZHY3, respectively. Addition of a small amount of ZHY1, ZHY2, or ZHY3 (0.03 in wt/wt) as the guest component in PM6:BTP-eC9 reduces the ππ-stacking distance and increases crystalline correlation length of both the PM6 and BTP-eC9 phases, hence accelerates charge separation, prolongates exciton lifetime, reduces non-radiative energy loss, increases charge mobilities, improves charge extraction and collection efficiency, and suppresses both monomolecular and bimolecular recombination, giving rise to a simultaneous photovoltaic performance and device stability. The host binary device and the ZHY3-based ternary device exhibit power conversion efficiencies of 18.3% and 19.5%, respectively. These results indicate that 3-benzofuranone and its derivatives are promising building blocks for designing asymmetrical nonfullerene acceptors towards high-efficiency photovoltaic materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.